MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

MDT

101.5

+1.85%↑

A

139.72

+1.42%↑

VEEV

225.69

+2.98%↑

HQY

87.23

+3.21%↑

NEOG

10.01

+4.6%↑

Search

Zimmer Biomet Holdings Inc

Open

SectorHealthcare

88.09 0.77

Overview

Share price change

24h

Current

Min

86

Max

88.51

Key metrics

By Trading Economics

Income

78M

231M

Sales

-76M

2B

P/E

Sector Avg

21.665

89.037

EPS

1.9

Dividend yield

1.08

Profit margin

11.552

Employees

17,000

EBITDA

63M

638M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+15.75% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.08%

2.18%

Next Earnings

10 lut 2026

Next Dividend date

30 sty 2026

Next Ex Dividend date

30 mar 2026

Market Stats

By TradingEconomics

Market Cap

-2.5B

17B

Previous open

87.32

Previous close

88.09

News Sentiment

By Acuity

10%

90%

11 / 360 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Zimmer Biomet Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 lis 2025, 19:38 UTC

Earnings

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 lis 2025, 17:00 UTC

Earnings

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Peer Comparison

Price change

Zimmer Biomet Holdings Inc Forecast

Price Target

By TipRanks

15.75% upside

12 Months Forecast

Average 100.47 USD  15.75%

High 120 USD

Low 88 USD

Based on 18 Wall Street analysts offering 12 month price targets forZimmer Biomet Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

18 ratings

4

Buy

11

Hold

3

Sell

Technical Score

By Trading Central

92.27 / 100.88Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

11 / 360 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat